BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 35562519)

  • 1. Stimulation of the atypical chemokine receptor 3 (ACKR3) by a small-molecule agonist attenuates fibrosis in a preclinical liver but not lung injury model.
    Van Loy T; De Jonghe S; Castermans K; Dheedene W; Stoop R; Verschuren L; Versele M; Chaltin P; Luttun A; Schols D
    Cell Mol Life Sci; 2022 May; 79(6):293. PubMed ID: 35562519
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential activity and selectivity of N-terminal modified CXCL12 chemokines at the CXCR4 and ACKR3 receptors.
    Jaracz-Ros A; Bernadat G; Cutolo P; Gallego C; Gustavsson M; Cecon E; Baleux F; Kufareva I; Handel TM; Bachelerie F; Levoye A
    J Leukoc Biol; 2020 Jun; 107(6):1123-1135. PubMed ID: 32374043
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ACKR3 Regulation of Neuronal Migration Requires ACKR3 Phosphorylation, but Not β-Arrestin.
    Saaber F; Schütz D; Miess E; Abe P; Desikan S; Ashok Kumar P; Balk S; Huang K; Beaulieu JM; Schulz S; Stumm R
    Cell Rep; 2019 Feb; 26(6):1473-1488.e9. PubMed ID: 30726732
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential Involvement of ACKR3 C-Tail in β-Arrestin Recruitment, Trafficking and Internalization.
    Zarca A; Perez C; van den Bor J; Bebelman JP; Heuninck J; de Jonker RJF; Durroux T; Vischer HF; Siderius M; Smit MJ
    Cells; 2021 Mar; 10(3):. PubMed ID: 33799570
    [No Abstract]   [Full Text] [Related]  

  • 5. Atypical Chemokine Receptor 3 "Senses" CXC Chemokine Receptor 4 Activation Through GPCR Kinase Phosphorylation.
    Schafer CT; Chen Q; Tesmer JJG; Handel TM
    Mol Pharmacol; 2023 Oct; 104(4):174-186. PubMed ID: 37474305
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ligand-specific conformational transitions and intracellular transport are required for atypical chemokine receptor 3-mediated chemokine scavenging.
    Montpas N; St-Onge G; Nama N; Rhainds D; Benredjem B; Girard M; Hickson G; Pons V; Heveker N
    J Biol Chem; 2018 Jan; 293(3):893-905. PubMed ID: 29180449
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Partial agonist activity of α1-adrenergic receptor antagonists for chemokine (C-X-C motif) receptor 4 and atypical chemokine receptor 3.
    Gao X; Abdelkarim H; Albee LJ; Volkman BF; Gaponenko V; Majetschak M
    PLoS One; 2018; 13(9):e0204041. PubMed ID: 30248140
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural basis of ligand interaction with atypical chemokine receptor 3.
    Gustavsson M; Wang L; van Gils N; Stephens BS; Zhang P; Schall TJ; Yang S; Abagyan R; Chance MR; Kufareva I; Handel TM
    Nat Commun; 2017 Jan; 8():14135. PubMed ID: 28098154
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutational Analysis of Atypical Chemokine Receptor 3 (ACKR3/CXCR7) Interaction with Its Chemokine Ligands CXCL11 and CXCL12.
    Benredjem B; Girard M; Rhainds D; St-Onge G; Heveker N
    J Biol Chem; 2017 Jan; 292(1):31-42. PubMed ID: 27875312
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological Characterization and Radiolabeling of VUF15485, a High-Affinity Small-Molecule Agonist for the Atypical Chemokine Receptor ACKR3.
    Zarca AM; Adlere I; Viciano CP; Arimont-Segura M; Meyrath M; Simon IA; Bebelman JP; Laan D; Custers HGJ; Janssen E; Versteegh KL; Buzink MCML; Nesheva DN; Bosma R; de Esch IJP; Vischer HF; Wijtmans M; Szpakowska M; Chevigné A; Hoffmann C; de Graaf C; Zarzycka BA; Windhorst AD; Smit MJ; Leurs R
    Mol Pharmacol; 2024 Mar; 105(4):301-312. PubMed ID: 38346795
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kinetics of CXCL12 binding to atypical chemokine receptor 3 reveal a role for the receptor N terminus in chemokine binding.
    Gustavsson M; Dyer DP; Zhao C; Handel TM
    Sci Signal; 2019 Sep; 12(598):. PubMed ID: 31506383
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human herpesvirus 8-encoded chemokine vCCL2/vMIP-II is an agonist of the atypical chemokine receptor ACKR3/CXCR7.
    Szpakowska M; Dupuis N; Baragli A; Counson M; Hanson J; Piette J; Chevigné A
    Biochem Pharmacol; 2016 Aug; 114():14-21. PubMed ID: 27238288
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Emerging Roles of the Atypical Chemokine Receptor 3 (ACKR3) in Cardiovascular Diseases.
    Duval V; Alayrac P; Silvestre JS; Levoye A
    Front Endocrinol (Lausanne); 2022; 13():906586. PubMed ID: 35846294
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification and functional characterization of arginine vasopressin receptor 1A : atypical chemokine receptor 3 heteromers in vascular smooth muscle.
    Albee LJ; LaPorte HM; Gao X; Eby JM; Cheng YH; Nevins AM; Volkman BF; Gaponenko V; Majetschak M
    Open Biol; 2018 Jan; 8(1):. PubMed ID: 29386406
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel insights into neuroinflammation: bacterial lipopolysaccharide, tumor necrosis factor α, and Ureaplasma species differentially modulate atypical chemokine receptor 3 responses in human brain microvascular endothelial cells.
    Silwedel C; Speer CP; Haarmann A; Fehrholz M; Claus H; Buttmann M; Glaser K
    J Neuroinflammation; 2018 May; 15(1):156. PubMed ID: 29792190
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Atypical chemokine receptor 3 induces colorectal tumorigenesis in mice by promoting β-arrestin-NOLC1-fibrillarin-dependent rRNA biogenesis.
    Yang J; Miao RR; Li YN; Pan T; Wu SH; Qu XJ; Cui SX
    Acta Pharmacol Sin; 2022 Nov; 43(11):2967-2976. PubMed ID: 35365782
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The chemokine X-factor: Structure-function analysis of the CXC motif at CXCR4 and ACKR3.
    Wedemeyer MJ; Mahn SA; Getschman AE; Crawford KS; Peterson FC; Marchese A; McCorvy JD; Volkman BF
    J Biol Chem; 2020 Oct; 295(40):13927-13939. PubMed ID: 32788219
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discovery and Development of First-in-Class ACKR3/CXCR7 Superagonists for Platelet Degranulation Modulation.
    Bayrak A; Mohr F; Kolb K; Szpakowska M; Shevchenko E; Dicenta V; Rohlfing AK; Kudolo M; Pantsar T; Günther M; Kaczor AA; Poso A; Chevigné A; Pillaiyar T; Gawaz M; Laufer SA
    J Med Chem; 2022 Oct; 65(19):13365-13384. PubMed ID: 36150079
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of cognate, non-cognate and synthetic CXCR4 and ACKR3 ligands on human lung endothelial cell barrier function.
    Cheng YH; Eby JM; LaPorte HM; Volkman BF; Majetschak M
    PLoS One; 2017; 12(11):e0187949. PubMed ID: 29125867
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structures of atypical chemokine receptor 3 reveal the basis for its promiscuity and signaling bias.
    Yen YC; Schafer CT; Gustavsson M; Eberle SA; Dominik PK; Deneka D; Zhang P; Schall TJ; Kossiakoff AA; Tesmer JJG; Handel TM
    Sci Adv; 2022 Jul; 8(28):eabn8063. PubMed ID: 35857509
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.